AML

MD IQ

Conference Coverage

CDK8 inhibitor shows activity against AML

DUBROVNIK, CROATIA – SEL120 looks active against acute myeloid leukemia in preclinical work, but experts aren’t sure why.

Conference Coverage

Venetoclax promising in unfit elderly AML patients

NEW YORK – Physicians are watching data on venetoclax, which has the potential to treat a subset of patients who can’t tolerate intensive therapy...

Pages